Arginine Therapy for Lung Diseases
Nitric oxide (NO) is produced by a family of isoenzymes, nitric oxide synthases (NOSs), which all utilize L-arginine as substrate. The production of NO in the lung and airways can play a number of roles during lung development, regulates airway and vascular smooth muscle tone, and is involved in inf...
Main Authors: | Jeremy A. Scott, Harm Maarsingh, Fernando Holguin, Hartmut Grasemann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.627503/full |
Similar Items
-
The clinical features of the overlap between COPD and asthma
by: Schroeder Joyce D, et al.
Published: (2011-09-01) -
Neutrophils Modulate Fibrogenesis in Chronic Pulmonary Diseases
by: Lili Ding, et al.
Published: (2021-04-01) -
The role of small airways in obstructive airway diseases
by: P-R. Burgel
Published: (2011-03-01) -
Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study
by: Baraket Melissa, et al.
Published: (2012-02-01) -
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to lung diseases and/or hypoxia
by: Husam Sakkijha, et al.
Published: (2014-01-01)